miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples-Reference-Cited by-同舟云学术

miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples

Published:2020-05-19 Issue: Volume:7 Page:
ISSN:2296-889X
Container-title:Frontiers in Molecular Biosciences
language:
Short-container-title:Front. Mol. Biosci.

Author:

Detassis Simone,del Vescovo Valerio,Grasso Margherita,Masella Stefania,Cantaloni Chiara,Cima Luca,Cavazza Alberto,Graziano Paolo,Rossi Giulio,Barbareschi Mattia,Ricci Leonardo,Denti Michela Alessandra

Publisher

Frontiers Media SA

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Biology,Biochemistry

Reference29 articles.

1. Roles for miR-375 in neuroendocrine differentiation and tumor suppression via notch pathway suppression in merkel cell Carcinoma.;Abraham;Am. J. Pathol.,2016

2. miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.;Arvidsson;Mod. Pathol.,2018

3. Heterogeneity of large cell carcinoma of the lung.;Barbareschi;Am. J. Clin. Pathol.,2011

4. MicroRNAs: target recognition and regulatory functions.;Bartel;Cell,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiplexed MicroRNA biomarker detection by bridging lifetime filtering imaging and dynamic chemical labeling;Sensors and Actuators B: Chemical;2024-10

2. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-05-21

3. SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues;The Analyst;2024

4. Bone Marrow Mesenchymal Stem Cells (BMSCs) Retard the Aggressive Migrating and Invading Activity of Non-Small Cell Lung Cancer Cells;Journal of Biomaterials and Tissue Engineering;2023-01-01

5. Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future;Journal of Clinical Medicine;2022-09-21